Related references
Note: Only part of the references are listed.Aerodynamics Effect of Holes in UAV Wings Modified for VTOL Capability
Laith S. Sawaqed et al.
DRONE SYSTEMS AND APPLICATIONS (2022)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017
Joseph J. Palamar et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2019)
Prevalence and epidemiological associates of novel psychedelic use in the United States adult population
James D. Sexton et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The relationships of classic psychedelic use with criminal behavior in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy
Alexander V. Kulikov et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Dino Luethi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Matthew W. Johnson et al.
NEUROPHARMACOLOGY (2018)
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Stephen V. Faraone
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
Esther Papaseit et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Varieties of the Psychedelic Experience: A Preliminary Study o f the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
Federico Zamberlan et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2018)
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2′S,4′S)-lysergic acid 2,4-dimethylazetidide (LSZ)
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2017)
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2016)
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines
Nicholas V. Cozzi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review
Rachel L. Tomko et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
Stephan Koehler et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Results of an international drug testing service for cryptomarket users
Fernando Caudevilla et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2016)
Sensation-seeking and domain-specific risk-taking behavior among adolescents: Risk perceptions and expected benefits as mediators
Lijin Zhang et al.
PERSONALITY AND INDIVIDUAL DIFFERENCES (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
A Fatality Related to Two Novel Hallucinogenic Compounds: 4-Methoxyphencyclidine and 4-Hydroxy-N-methyl-N-ethyltryptamine
Iain M. McIntyre et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2015)
Psilocybin, psychological distress, and suicidality
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Sensation-Seeking and Risk-Taking Behaviors: A Study on Young Iranian Adults
Siamak Khodarahimi
APPLIED RESEARCH IN QUALITY OF LIFE (2015)
Psychoactive Substances in Prehistoric Times: Examining the Archaeological Evidence
Elisa Guerra-Doce
TIME & MIND-THE JOURNAL OF ARCHAEOLOGY CONSCIOUSNESS AND CULTURE (2015)
Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2c Agonists
Martin Hansen et al.
ACS CHEMICAL NEUROSCIENCE (2014)
A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches
Markus R. Meyer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2014)
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
Amy J. Eshleman et al.
PSYCHOPHARMACOLOGY (2014)
My Friend Said it was Good LSD: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion
Joji Suzuki et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
Enric Alvarez et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Consumption of new psychoactive substances in a Spanish sample of research chemical users
Debora Gonzalez et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
Fernando Caudevilla-Galligo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Persistent psychosis after ingestion of a single tablet of '2C-B'
Hsiang Hsuan Huang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis
Meredith A. Fox et al.
PSYCHOPHARMACOLOGY (2010)
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):: A high-affinity 5-HT2A receptor-selective agonist radioligand
David E. Nichols et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents
William E. Fantegrossi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
The Sensation Seeking Trait and Substance Use: Research Findings and Clinical Implications
Michael T. Bardo et al.
CURRENT PSYCHIATRY REVIEWS (2007)
SAR of psilocybin analogs:: Discovery of a selective 5-HT2C agonist
H Sard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes
CA Villalobos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD)
DE Nichols et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Short screening scales to monitor population prevalences and trends in non-specific psychological distress
RC Kessler et al.
PSYCHOLOGICAL MEDICINE (2002)
Share Paper
